Said, D., Hussein, K., Hussein, M., Ahmad, E. (2024). Serum Interleukin-15 Evaluation in Vitiligo Patients. Benha Journal of Applied Sciences, 9(9), 91-97. doi: 10.21608/bjas.2024.323867.1507
Dalia Karam Said; Khaled Mohey Hussein; Mohamed Saber Hussein; Enas Sebaey Ahmad. "Serum Interleukin-15 Evaluation in Vitiligo Patients". Benha Journal of Applied Sciences, 9, 9, 2024, 91-97. doi: 10.21608/bjas.2024.323867.1507
Said, D., Hussein, K., Hussein, M., Ahmad, E. (2024). 'Serum Interleukin-15 Evaluation in Vitiligo Patients', Benha Journal of Applied Sciences, 9(9), pp. 91-97. doi: 10.21608/bjas.2024.323867.1507
Said, D., Hussein, K., Hussein, M., Ahmad, E. Serum Interleukin-15 Evaluation in Vitiligo Patients. Benha Journal of Applied Sciences, 2024; 9(9): 91-97. doi: 10.21608/bjas.2024.323867.1507
Serum Interleukin-15 Evaluation in Vitiligo Patients
1Department of Dermatology, Venereology & Andrology
Faculty of Medicine - Benha University
2Professor of Dermatology, Venereology and Andrology Faculty of Medicine- Benha University
3Assistant Professor of Dermatology, Andrology and Venereology Faculty of Medicine Benha University
4Assistant Professor of Clinical and Chemical Pathology Faculty of Medicine - Benha University
Abstract
Background: Immune dysregulation has been linked to vitiligo, a skin condition marked by areas of uneven pigmentation. The role of serum interleukin-15 (IL-15) levels in the development of vitiligo is not yet understood. This research set out to compare the blood IL-15 levels of healthy controls to those of vitiligo sufferers. Methods: Sixty people with vitiligo and twenty healthy people served as controls in this case-control study. The ELISA kits were used to test the levels of serum IL-15. A thorough evaluation was carried out, which included the Vitiligo Extent Tensity Index (VETI). The outcomes are: The median blood IL-15 levels in the patients were substantially greater than those in the controls (94 pg/ml compared to 25.4 pg/ml; P<0.001). The length of the illness had a positive correlation with VETI scores (r = 0.772, P< 0.001), whereas the age of vitiligo beginning had a negative correlation (r = -0.358, P = 0.005). A favorable correlation was seen between IL-15 and the VETI score (r = 0.757, P< 0.001), the duration of the condition (r = 0.713, P< 0.001), and the age at which vitiligo first appeared (r = 0.324, P = 0.011).